Downey, California (PRWEB) January 16, 2018
Dr. Kyle Greene is a highly dedicated Hematologist/Oncologist that brings extensive medical knowledge and research to The Oncology Institute of Hope and Innovation.
Dr. Greene began his undergraduate education in 2002 at Weber State University, Ogden, Utah and then transferred to The University of Utah in Salt Lake City where he received a B.S. in Biology and a minor in Chemistry. He then moved to New York to complete his medical degree from Albany Medical College, in Albany, New York. In 2012, Dr. Greene moved to Los Angeles to complete his internal medicine Internship and Residency at Kaiser Permanente Los Angeles, a UCLA affiliated hospital. He completed his fellowship at Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah.
Dr. Greene, has completed over five research projects including a Data collection phase of multicenter retrospective evaluation of patient outcomes with grade 3a follicular lymphoma, particularly those treated with bendamustine versus anthracycline based therapies. He has both clinical and hospital experience.
Medical Board of California
American Society of Internal Medicine
State of Utah Physicians and Surgeon and controlled substance
United States Department of Justice DEA
Patient Care Philosophy
Dr. Greene’s believes in individualizing his patient care to cater to each patient He believes that communication is highly important and always urges his patients to stay active in their patient care plan.